As reported on PharmaBiz, GENESIS Pharma has announced an exclusive agreement with Otsuka Pharmaceutical Europe Ltd. (OPEL) to distribute and commercialize donidalorsen across 14 Central
As reported on PharmaBiz, Renalys Pharma has reported encouraging topline data from its Phase III trial evaluating sparsentan (RE-021), an oral dual endothelin and angiotensin
Gilead Sciences announced positive topline results from the Phase 3 ARTISTRY-2 trial on December 15, 2025 and reported by Drugs.com, marking a significant advancement in
As reported on BioPharmaDive, the U.S. Food and Drug Administration (FDA) has granted early approval for a new frontline treatment option for HER2-positive metastatic breast
A groundbreaking study published in Neurology and reported by Drugs.com reveals that adults with type 2 diabetes who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs),
I’m Nella, and this is part of my journey with Metabolic dysfunction-associated steatohepatitis (MASH). I was diagnosed with MASH in early 2024, after being
When we hear the word diet, most of us automatically think of food. But what about our thoughts? Let’s look at them in terms of
When life-threatening pustules suddenly erupt across the body accompanied by systemic inflammation, generalized pustular psoriasis (GPP) patients face a medical crisis with few treatment options.
Editor’s Note: This story share was submitted by Beverly Smith, a retired schoolteacher from Canada. I was diagnosed after treatment for PTSD and having had
As featured on KFF News, Heidi DiLorenzo was preparing to welcome her second child, and her biggest concern wasn’t taking Zoloft. The Birmingham attorney had
Eccogene, a clinical-stage biopharmaceutical company, has announced enrollment of the first patient in MOSAIC, a Phase 2a clinical trial investigating two novel oral small molecules
Editor’s Note: This poem, originally written by Spence Shishido, was shared with Patient Worthy by our friends at Elephants & Tea. To see the poem
This charity has been set up to offer research based and lived experience, advice and support. Aims: To support any individual of any age with
As reported by Healio, the U.S. Food and Drug Administration (FDA) has officially qualified AIM-MASH AI Assist, marking a milestone as the first artificial intelligence
Sixteen years ago, Nate Appleman, a celebrated chef, faced every parent’s worst nightmare when his two-year-old son, Oliver, fell ill. Oliver’s diagnosis was a complete
My name is Jessica Glaspie, and I have been living with HIV for over 15 years! A lot of people think that life and love
GSK announced a significant milestone in respiratory medicine as the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of
Lumos Labs has received FDA 510(k) approval for LumosityRx, a prescription version of its well-known Lumosity brain training platform. As reported by Fierce BioTech, The
🧠 ADHD isn’t just about being easily distracted—it’s a unique way the brain processes attention and energy. Understanding these differences can help people approach tasks, learning, and focus with more patience and strategy. ✨
💡 Tip: Small adjustments to your environment or routines can make a big difference in managing attention and productivity. #ADHD #ADHDAwareness #ShareYourStory #PatientWorthy
If you're interested in sharing your story, click here: bit.ly/4dV7gru
This week on Patient Worthy's site, we're shining a spotlight on Attention-Deficit/Hyperactivity Disorder (ADHD). Throughout the week, we’ll be sharing valuable insights, exploring potential treatment options, and creating space for patients and caregivers to share their personal journeys.
If you're interested in learning more or joining the conversation, visit Patientworthy.com for the latest updates.
Have a story to share? Click the link below, we'd love to hear from you!
bit.ly/4dV7gru
#ADHD #PatientWorthy #ShareYourStory
A new gene therapy that targets oligodendrocytes shows promise in the treatment of Canavan disease. Read more here:
patientworthy.com/2026/01/20/oligodendrocyte%e2%80%91targeted-gene-therapy-shows-breakthrough-pot...
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
